Zealand Pharma

Description. Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide therapeutics-based medicines in Denmark. It has a portfolio of proprietary medicines in late-stage clinical development focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide for the treatment... Company profile page for Zealand Pharma A/S including stock price, company news, press releases, executives, board members, and contact information Zealand Pharma is a biotech company with leading-edge scientific expertise in turning peptides into medicines. Zealand has a growing proprietary pipeline of novel specialty drug candidates and a mature portfolio of products and projects under license collaborations with Sanofi, Helsinn Healthcare and Boehringer Ingelheim.

Rhythm

Rhythm U.S.A., Inc. was incorporated in the State of New York in 1989, as the subsidiary of Rhythm Watch Co., Ltd. of Japan and moved to Atlanta, Georgia in 1991. Lidocaine, sold under the brand names Akten, Glydo, and Lidoderm, relieves pain when applied to the skin via cream, gel, or patch. Lidocaine can also be given through the veins before surgical ... 1997. 4年間情熱をそそぎつづけるが情報量の少なさにオーストラリアへ修行に行く事を決意。オーストラリアではディジュリドゥショップで働きながら、道で演奏をするバスキングというスタイルから活動 …

OxThera

How can the answer be improved? OxThera is built on a highly-experienced and committed team and strong network in oxaluria research, rare disease drug development and anaerobic bacterial manufacturing. We are supported by an experienced and dedicated group of life science investors. Information on valuation, funding, cap tables, investors, and executives for OxThera . Use the PitchBook Platform to explore the full profile .

Biophytis

Aug 02, 2019 · Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Jul 22, 2019 · Biophytis SA is a holding company, which engages in the clinical development of therapeutics to restore the muscular and visual functions in … Company profile page for Biophytis SA including stock price, company news, press releases, executives, board members, and contact information Skip To Content Skip to content

Biophytis

Aug 02, 2019 · Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Jul 22, 2019 · Biophytis SA is a holding company, which engages in the clinical development of therapeutics to restore the muscular and visual functions in … Company profile page for Biophytis SA including stock price, company news, press releases, executives, board members, and contact information Skip To Content Skip to content

Zafgen

Aug 03, 2019 · Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. See the company profile for Zafgen, Inc. (ZFGN ) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ... Jul 18, 2019 · Zafgen, Inc., incorporated on November 22, 2005, is a clinical-stage biopharmaceutical company. The Company uses its proprietary methionine aminopeptidase 2 …

PerkinElmer

Description. PerkinElmer , Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers analytical technologies,... Full Description. PerkinElmer , Inc ., incorporated on November 13, 1947, is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions. Company Profile . PerkinElmer makes tools to find out whats in you and your environment. It develops and sells equipment that researchers use to identify and treat diseases and to analyze food products as well as air, water, and soil to identify impurities and contaminants. The company, which distributes its offerings in more than 150 countries,...

Eternygen

How can the answer be improved? Information on valuation, funding, cap tables, investors, and executives for Eternygen . Use the PitchBook Platform to explore the full profile . Eternygen GmbH operates as a biotechnology company. The Company offers research and development of new medicines and drugs for metabolic diseases. Eternygen conducts its operations in …

Pronutria Biosciences

Axcella is designing and developing novel endogenous metabolic modulator compositions to safely reprogram metabolic dysregulation. We are transforming the discovery and development of traditional drug and consumer health candidates from concept to clinical stages, by … Sep 30, 2015 · Pronutria Biosciences is looking to blaze a trail regulating amino acids through a new class of regenerative therapeutics. If successful, Pronutria could provide new treatment options for multiple medical conditions, including muscular, metabolic and some liver conditions. Jun 07, 2016 · CAMBRIDGE, Mass., June 7, 2016 – Pronutria Biosciences today announced that it has changed its corporate name to Axcella Health to better reflect its mission of harnessing amino acids for cell health through a systems pharmacology approach. The company uses oral protein biologics to precisely deliver disease-specific amino acid profiles that have systems-wide effects, which restore …

MedGenome

Employees at MEDGENOME How can the answer be improved? Please select your region. UNITED STATES & EUROPE. INDIA & ASIA

CellCentric

How can the answer be improved? Developer of pharmaceuticals designed to treat cancer . The companys pharmaceuticals are small-molecule inhibitors that targets a deubiquitinase enzyme associated with prostate cancer, enabling physicians to treat cancer in an enhanced way. CellCentric Ltd CellCentric Ltd. is a drug discovery company with a foundation in epigenetics. The Company focuses on first-in-class inhibitors of the bromodomain of …

Nimbus Therapeutics

Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology. September 10, 2019. Leading Biotech: Boston BD VIEW ALL. Our CEO’s Tweets Our CEO’S Tweets VIEW ALL. location. 130 Prospect Street, Suite 301 Cambridge, MA 02139 USA. call US. 857-999-2009. EMAIL US. info@nimbustx.com Nimbus Therapeutics , LLC . operates as a biotechnology company . The Company discovers and develops medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer, and ... Nimbus Therapeutics . The companys services integrate computational chemistry, the symbiotic relationship, advanced technologies, focus on targets in metabolic disease, oncology and inflammation and is a paradigm changer, enabling clients to meet their unmet medical need and high-value targets in the metabolism-oncology-immunology triad.

Mitobridge

How can the answer be improved? Mitobridge utilizes an integrated platform of assays and models to systematically evaluate disease-related changes in mitochondrial function and delivers innovative medicines. Given the myriad of roles that mitochondria play in cellular homeostasis, it is no surprise that defects in mitochondrial function can lead to a broad spectrum of diseases. Jul 19, 2019 · Mitobridge , Inc., a biotechnology company, discovers and develops novel small molecule therapeutics that improve mitochondrial functions.

Exelixis

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. Aug 02, 2019 · Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. Exelixis, Inc., incorporated on November 15, 1994, is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and ...

Inc.

An Inc. Verified Profile is the perfect tool for helping entrepreneurs and small companies showcase their companies in attention-grabbing context. Whether you want to drum up new customers, seek ... Visit Inc.com for the latest issue of Inc . Magazine and get advice, tools, and services that help your small business grow. Aug 03, 2019 · Immunic Inc . company facts, information and stock details by MarketWatch. View imux business summary and other industry information.

Outpost Medicine

Outpost Medicine was founded in 2016. Who are Outpost Medicine key executives? Outpost Medicines key executives are Gordon McMurray, Ian Mills and Gale Kennedy. How many employees does Outpost Medicine have? Outpost Medicine has 10 employees. Who are Outpost Medicine competitors ? Competitors of Outpost Medicine include Moderna Therapeutics, AMAG … Company profile page for Outpost Medicine LLC including stock price, company news, press releases, executives, board members, and contact information Skip To Content Skip to content Information on valuation, funding, cap tables, investors, and executives for Outpost Medicine . Use the PitchBook Platform to explore the full profile .

For More information, Please access Read the total report.